SynbioTech’s TWK10 Receives Approval to Enhance Muscle Strength

SynbioTech Inc., a leader in the probiotics industry, has received approval for its flagship product, Lactiplantibacillus plantarum TWK10®, designed to enhance muscle strength. The approval comes from the Thai government, marking a significant step in the company’s strategy to expand into the Southeast Asian market. With a growing reputation as one of the world’s top 20 probiotic suppliers, SynbioTech aims to leverage this approval to capture a share of the burgeoning probiotic supplement market.

The recognition of TWK10® is underscored by its impressive track record. The probiotic has won multiple awards across Europe, the United States, and Japan, with clinical trials demonstrating its effectiveness in increasing muscle mass and reducing body fat. As part of its promotional efforts, SynbioTech will present TWK10® and other products at the upcoming Vitafoods Asia 2025 event in Bangkok from September 17-19, where it will showcase the multifunctional health benefits of its products.

Market Growth and Strategic Expansion

According to research from Mordor Intelligence, the probiotic supplement market in the ASEAN region is projected to reach USD 198.05 billion by 2030, growing at a compound annual growth rate (CAGR) of 11.43% from 2025 to 2030. This rapid growth is attributed to increasing awareness of healthy aging among consumers, providing a robust opportunity for SynbioTech to expand its footprint.

Sean Yang, General Manager of SynbioTech Inc., emphasized the company’s commitment to the Southeast Asian market, particularly Thailand, where TWK10® was officially listed as an edible microbial strain in 2024. This milestone not only enhances SynbioTech’s prospects in Thailand but also paves the way for collaborations with local partners.

The efficacy of TWK10® has been validated through eight clinical trials, establishing its ability to boost muscle strength, enhance endurance, and improve mobility among older adults. SynbioTech is well-positioned to develop precision health products, supported by advanced research and development centers and high-standard manufacturing facilities.

Innovative Technology and Future Plans

A key aspect of SynbioTech’s strategy is its patented SYNTEK® fermentation technology, which allows for diverse product formats and a comprehensive contract development and manufacturing organization (CDMO) platform. This technology facilitates strain development, clinical validation, custom formulation, and smart packaging solutions, creating a one-stop shop for clients in the health and wellness sector.

Looking ahead, SynbioTech is dedicated to broadening its portfolio of applications, integrating probiotics and postbiotics into everyday wellness solutions. As the company prepares to showcase its innovations at Vitafoods Asia, it aims to lead the next wave of advancements in sports nutrition, healthy aging, and overall vitality. With 25 years of extensive experience, SynbioTech is poised to make a lasting impact on the global probiotic market.